HOXB13 and neoplasm: Nevertheless, our results support differential DNA methylation of HOXB13 between SP-EP and MPE and suggest targeted HOXB13 methylation analysis as a further molecular test option to distinguish between the two tumor types in the diagnostic setting, e.g., when immunohistochemistry for HOXB13 is inconclusive.